Yi‐Bin Chen

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.563Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD

Blood Advances(2024)10.1182/bloodadvances.2024012561

Top 35%

0.563DataRank

Top 35%19 citations

Haesook T. Kim, Nikolaos Spyrou, Nikolaos Katsivelos, Steven Kowalyk, Gilbert Eng +22 more

Papers

Driven by 28 papers — median percentile 65. Top paper: “Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial”.

Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial

Blood(2020)10.1182/blood.2020004823

N/A

7.0DataRank · unranked

307 citations

Miguel‐Angel Perales, Mark A. Schroeder, Haris Ali, Nirav N. Shah, Yi‐Bin Chen +8 more

Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial

Blood(2022)10.1182/blood.2021014738

N/A

4.5DataRank · unranked

141 citations

Jörg Dietrich, Kathleen Gallagher, Mark Roschewski, Justin T. Jordan, Deborah Forst +22 more

A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation

Blood(2020)10.1182/blood.2019004710

N/A

2.8DataRank · unranked

99 citations

Haesook T. Kim, Caitlin Costello, Alex F. Herrera, Frederick L. Locke, Rodrigo Maegawa +20 more

PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation

Blood Advances(2020)10.1182/bloodadvances.2019000784

N/A

2.0DataRank · unranked

65 citations

Philippe Armand, Robert Redd, Erin Jeter, Reid W. Merryman, Kimberly C. Coleman +21 more

JAK inhibition in a patient with a STAT1 gain-of-function variant reveals STAT1 dysregulation as a common feature of aplastic anemia

Med(2022)10.1016/j.medj.2021.12.003

N/A

1.1DataRank · unranked

24 citations

Joshua M. Peters, Travis Hughes, Caleb A. Lareau, Leif S. Ludwig, Lucas R. Massoth +12 more

Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin

Blood Advances(2020)10.1182/bloodadvances.2020003336

N/A

1.0DataRank · unranked

38 citations

Zachariah DeFilipp, Umut Özbek, Karamjeet Sandhu, Aaron Etra, Hannah Choe +24 more

Effective treatment of low-risk acute GVHD with itacitinib monotherapy

Blood(2022)10.1182/blood.2022017442

N/A

0.915DataRank · unranked

44 citations

Alexandra Capellini, Amin Alousi, Monzr M. Al Malki, Hannah Choe, Zachariah DeFilipp +25 more

Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease

Blood Advances(2023)10.1182/bloodadvances.2023009853

N/A

0.794DataRank · unranked

25 citations

Kaitlyn London, Janna Baez, Yu Akahoshi, William J. Hogan, Aaron Etra +32 more

Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract

Blood Advances(2024)10.1182/bloodadvances.2024012556

N/A

0.724DataRank · unranked

23 citations

Ashish Damania, Haesook T. Kim, Chia‐Chi Chang, Areej El‐Jawahri, Steven L. McAfee +20 more

Immune Reconstitution following High-Dose Chemotherapy and Autologous Stem Cell Transplantation with or without Pembrolizumab Maintenance Therapy in Patients with Lymphoma

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.10.010

N/A

0.618DataRank · unranked

17 citations

Robert Redd, Erin Jeter, Jeff L. Wong, Kristin M McHugh, Carol Reynolds +21 more

A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma

Blood(2023)10.1182/blood.2023020244

N/A

0.598DataRank · unranked

15 citations

Parastoo B. Dahi, Robert Redd, Mikaela M. McDonough, Yi‐Bin Chen, Zachariah DeFilipp +15 more

The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD

Blood Advances(2024)10.1182/bloodadvances.2024012561

Top 35%

0.563DataRank

Top 35%19 citations

Haesook T. Kim, Nikolaos Spyrou, Nikolaos Katsivelos, Steven Kowalyk, Gilbert Eng +22 more

Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia

Bone Marrow Transplantation(2024)10.1038/s41409-024-02449-2

N/A

0.480DataRank · unranked

10 citations

Niveditha Ravindra, Pranay S. Hegde, Georgia Andrew, Devdeep Mukherjee, Zoë C. Wong +18 more

Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia

Bone Marrow Transplantation(2024)10.1038/s41409-024-02447-4

N/A

0.480DataRank · unranked

10 citations

Niveditha Ravindra, Pranay S. Hegde, Georgia Andrew, Devdeep Mukherjee, Zoë C. Wong +18 more

Protocol for multi-site randomized trial of inpatient palliative care for patients with hematologic malignancies undergoing hematopoietic stem cell transplantation

Contemporary Clinical Trials(2024)10.1016/j.cct.2024.107460

N/A

0.323DataRank · unranked

6 citations

Richard Newcomb, Alison R. Kavanaugh, Dania A. Khalil, Joseph A. Greer, Yi‐Bin Chen +6 more

Single-center experience using anakinra for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS)

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-003847

N/A

0DataRank · unranked

130 citations

Kathleen Gallagher, Yi‐Bin Chen, Mark B. Leick, Steven L. McAfee, Areej El‐Jawahri +11 more

Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD

Blood Advances(2023)10.1182/bloodadvances.2023009885

N/A

0DataRank · unranked

42 citations

Nikolaos Spyrou, William J. Hogan, Francis Ayuk, Zachariah DeFilipp, Daniela Weber +31 more

An N-of-1 Trial of Itacitinib for a Patient with Aplastic Anemia Associated with a Gain-of-Function Variant in STAT1

Research Square(2021)10.21203/rs.3.rs-139401/v1

N/A

0DataRank · unranked

1 citations

Travis Hughes, Joshua M. Peters, Caleb A. Lareau, Leif S. Ludwig, Lucas R. Massoth +8 more

The utility of biomarkers in acute GVHD prognostication

Blood Advances(2023)10.1182/bloodadvances.2023009929

N/A

0DataRank · unranked

18 citations

Yu Akahoshi, Francis Ayuk, Ernst Holler, Hannah Choe, Aaron Etra +29 more

Donor clonal hematopoiesis and recipient outcomes after transplantation

medRxiv(2021)10.1101/2021.09.25.21263697

N/A

0DataRank · unranked

16 citations

Haesook T. Kim, Lin Zhao, H. Moses Murdock, Bryan C. Hambley, Alana F. Ogata +24 more

Spatial transcriptomics reveals distinct tissue niches linked with steroid responsiveness in acute gastrointestinal GVHD

Blood(2023)10.1182/blood.2023020644

N/A

0DataRank · unranked

9 citations

Michael J. Raabe, Evan R. Lang, Yuhui Song, Chenyue Lu, Vikram Deshpande +6 more

Distress in a Pandemic: Association of the Coronavirus Disease-2019 Pandemic with Distress and Quality of Life in Hematopoietic Stem Cell Transplantation

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.09.001

N/A

0DataRank · unranked

14 citations

Carlisle E. W. Topping, Madison A. Clay, Matthew J. Reynolds, Julia Rice, Lauren E. Harnedy +9 more

Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.08.016

N/A

0DataRank · unranked

18 citations

Edward A. Stadtmauer, John E. Levine, Karen K. Ballen, Yi‐Bin Chen, Amy E. DeZern +20 more

Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD

Blood Advances(2024)10.1182/bloodadvances.2023011049

N/A

0DataRank · unranked

14 citations

Najla El Jurdi, Nikolaos Katsivelos, Deukwoo Kwon, Stephanie Gergoudis, George Morales +33 more

A Day 14 Endpoint for Acute GVHD Clinical Trials

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.01.079

N/A

0DataRank · unranked

11 citations

Yu Akahoshi, Steven Kowalyk, George Morales, Rahnuma Beheshti, Paibel Aguayo‐Hiraldo +36 more

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma

Leukemia(2021)10.1038/s41375-021-01193-6

N/A

0DataRank · unranked

83 citations

Luca Castagna, Laura Giordano, Vincent T. Ho, Paolo Corradini, Anna Guidetti +61 more

Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study

Journal of Clinical Oncology(2021)10.1200/jco.21.01891

N/A

0DataRank · unranked

94 citations

Claire A. Pernat, Alexander Gavralidis, Kerri St. Denis, Evan C. Lam, Laura M. Spring +41 more

Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502

UNC Libraries(2020)10.17615/d8vv-vc17

N/A

0DataRank · unranked

0 citations

William Blum, Flora Mulkey, Richard M. Stone, Shelly Carter, Charles Linker +15 more

Yi‐Bin Chen

Indexed papers

Top data-sharing exemplar

Papers